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Cochrane Collaborative Review Group on Peripheral Vascular Diseases:
Review Abstracts
Introduction Abstracts
The following abstracts are part of an ongoing series Abstract. Injection sclerotherapy for varicose veins
P. V. Tisi and C. A. Beverleyof articles produced by the Cochrane Collaborative
Review Group on Peripheral Vascular Diseases, which Date of most recent substantive amendment: 13 September
2001is part of the Cochrane Collaborative. The review is
published in full on The Cochrane Library, a quarterly
electronic journal available on CD-ROM and via the
Internet. The electronic format allows Cochrane re-
Backgroundviews to accommodate new data as they become avail-
able, making the library a consistently up-to-date
Injection sclerotherapy for varicose veins has beensource of information over time.
used widely since 1963, following popularisation ofCertain abstracts appearing on the Cochrane Library
the technique by Fegan. The treatment aims to ob-may be presented in a simpler, less scientific format
literate the lumen of varicose veins or thread veins,than the abstracts presented here to permit greater
however, there is limited evidence regarding its ef-accessibility to the public. However, the substance of
ficacy.both versions is the same. Cochrane reviews are now
indexed on MedLine.
If you are interested in writing a Cochrane review
or contributing to the activities of the Cochrane Peri-
Objectivespheral Vascular Diseases Group please contact:
To determine whether sclerotherapy is effective inProfessor FGR Fowkes
Cochrane Collaborative Review Group on terms of symptomatic improvement and cosmetic ap-
pearance; has an acceptable complication rate; and toPeripheral Vascular Diseases
Public Health Sciences define rates of symptomatic or cosmetic varicose vein
recurrence following sclerotherapy.University of Edinburgh
Teviot Place
Edinburgh EH8 9AG
Tel. +44 (0) 131 650 3220
Search strategyFax. +44 (0) 131 650 6904
Any comments or criticisms on Cochrane reviews/ Publications describing randomised controlled trials
abstracts should be made through the comments/ (RCTs) of injection sclerotherapy for varicose veins
criticisms facility on the Cochrane Library, or by con- (excluding comparisons with surgery) were sought
tacting the group at the above address. through EMBASE and MEDLINE (from inception to
March 2001) and hand-searching relevant journals,
using the search strategy described by the Cochrane
Peripheral Vascular Diseases Review Group. Bib-
liographies of papers identified were examined for
1078–5884/02/020097+03 $35.00/0  2002 Elsevier Science Ltd. All rights reserved.
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further RCTs. Manufacturers of sclerosants were con- current place of sclerotherapy in modern clinical prac-
tice, which is usually limited to treatment of recurrenttacted for further trial information.
varicose veins following surgery, and thread veins. A
comparison of surgery versus sclerotherapy would be
valuable.
Selection criteria
RCTs of injection sclerotherapy versus graduated com- Abstract. Horse chestnut seed extract for chronic
pression stockings or “observation”, or comparing venous insufficiency
different sclerosants, doses and post-compression M. H. Pittler and E. Ernst
bandaging techniques on patients with symptomatic Date of most recent substantive amendment: 22 November
and/or cosmetic varicose veins or thread veins were 2001
considered for inclusion in the review.
Background
Data collection and analysis
Conservative therapy of chronic venous insufficiency
Ten studies were included in the analysis. These com- (CVI) consists largely of compression treatment. How-
pared: sodium tetradecyl sulphate (STD) versus an ever, this often causes discomfort and has been as-
alternative sclerosant; sclerosant with or without local sociated with poor compliance, which renders oral
anaesthetic; application of Molefoam versus Sorbo drug treatment an attractive option.
pads to injection sites; elastic compression bandaging
versus conventional bandaging: and short-term band-
aging versus standard bandaging. Data were ab-
stracted by both authors. Objectives
To review the evidence from rigorous clinical trials
assessing the efficacy and safety or oral horse chestnut
Main results seed extract (HCSE) versus placebo, or reference ther-
apy for the treatment of CVI.
No RCTs compared sclerotherapy to graduated com-
pression stockings or other non-surgical treatments.
Two studies compared STD to alternative sclerosants
and found no significant differences in outcome or Search strategy
complication rates. Adding local anaesthetic to scl-
erosant reduced the pain from injection (one study) Publications describing randomised controlled trials
but had no other effects. Comparison of Molefoam (RCTs) of HCSE for chronic venous insufficiency were
and Sorbo pad pressure dressings found no difference sought through EMBASE, MEDLINE, Amed, and Phy-
in outcome for erythema (redness) or successful sclero- tobase (from inception to January 2001), the Cochrane
sis. The degree and duration of elastic compression Controlled Trials Register (Issue 1, 2001) and the Spe-
had no significant effect on varicose vein recurrence cialised Trials Register of the Cochrane Peripheral
rates, cosmetic appearance or symptomatic im- Vascular Diseases Group (April 2001). Manufacturers
provement. Increased compression prevented slipping of HCSE preparations and experts on the subject were
of dressings but caused increased discomfort, as did contacted and asked to contribute published and un-
increasing duration of compression. published material. There were no restrictions on the
language of publication.
Reviewers’ conclusions
Selection criteria
Evidence from RCTs suggests that type of sclerosant,
local pressure dressing, degree and length of com- Randomised controlled trials of oral HCSE mono-
preparations for patients with CVI were included.pression have no significant effect on the efficacy of
sclerotherapy for varicose veins. This supports the Trials comparing HCSE with placebo or reference
Eur J Vasc Endovasc Surg Vol 23, February 2002
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medications were included. Trials assessing HCSE as Leg pain was assessed in six placebo-controlled trials
that reported a significant reduction of leg pain in theone of several active components in a combination
preparation or as a part of a combination treatment HCSE groups compared with the placebo groups.
One trial, which reported adequate data suggested awere excluded.
weighted mean difference (WMD) of 42.4 mm [95%
confidence interval (CI) 34.9–49.9] measured on a
100 mm visual analogue scale. Leg volume was as-
Data collection and analysis sessed in five placebo-controlled trials. Meta-analysis
of four trials (n=239) reporting adequate data sug-
Data were extracted systematically and method- gested a significant reduction in favour of HCSE com-
ological quality was evaluated using a standard scor- pared with placebo (WMD 58.6 ml [95% CI 24.9–92.2]).
ing system. The screening of studies, selection, data One trial indicated that HCSE may be as effective as
extraction and the assessment of methodological qual- treatment with compression stockings. Adverse effects
ity were performed independently by two reviewers. are usually mild and infrequent.
Disagreements concerning evaluation of individual
trials were resolved through discussion.
Reviewers’ conclusions
The evidence presented implies that HCSE is an ef-Main results
ficacious and safe short-term treatment for CVI. How-
ever several caveats exist and more rigorous RCTs areOverall, the included placebo controlled trials suggest
an improvement in CVI related signs and symptoms. required to assess the efficacy of this treatment option.
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